XCUR
Exicure IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$22.69M
P/E Ratio
—
EPS
$-0.79
Beta
4.01
52W High
$11.86
52W Low
$3.10
50-Day MA
$4.00
200-Day MA
$5.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Exicure Inc
Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-3.29M |
| EBITDA | $-9.88M |
| Operating Margin | 0.00% |
| Return on Equity | -92.50% |
| Return on Assets | -43.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.62 |
| Price-to-Book | 5.57 |
| Price-to-Sales (TTM) | 13.61 |
| EV/Revenue | 27.17 |
| EV/EBITDA | -0.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 928.00% |
| Shares Outstanding | $6.37M |
| Float | $3.38M |
| % Insiders | 35.38% |
| % Institutions | 2.49% |
Historical Volatility
HV 10-Day
43.70%
HV 20-Day
52.73%
HV 30-Day
55.08%
HV 60-Day
63.08%
HV Rank
0.0%
Volatility is currently contracting
Data last updated: 4/28/2026